<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/292"/><api:result><api:object category="publication" id="292" last-affected-when="2024-03-18T00:27:35.73+00:00" last-modified-when="2024-03-18T00:27:35.73+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/292" created-when="2010-05-17T13:46:16.303+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-01-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="2467209" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1023/a:1006254402163" last-modified-when="2022-09-11T03:53:37.407+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rainsford</api:last-name><api:initials>KD</api:initials><api:first-names>KD</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Chindemi</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Delaney</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1023/a:1006254402163</api:text><api:links><api:link type="doi" href="http://doi.org/10.1023/a:1006254402163"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1023/a:1006254402163"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0165-7380</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Veterinary Research Communications</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>101</api:begin-page><api:end-page>113</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1023/a:1006254402163</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>27</api:day><api:month>12</api:month><api:year>2012</api:year></api:date></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>23</api:text></api:field></api:native></api:record><api:record format="native" id="94636" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032960643" last-modified-when="2021-12-08T07:45:21.29+00:00"><api:citation-count>31</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>NSAIDs are a major cause for concern for their propensity to cause joint deterioration in canine, as in human, patients receiving these drugs for treatment of pain in osteoarthritis and other acute and chronic painful conditions. To determine the potential effects of the new NSAID meloxicam on cartilage integrity, the effects of this drug on proteoglycan biosynthesis in vitro and ex vivo were compared with those of indomethacin, a known inhibitor of sulphated proteoglycans that accelerates joint injury in human osteoarthritis. In vitro cartilage proteoglycan synthesis from a radiosulphate precursor was unaffected by 0.5-10.0 μmol/L meloxicam but was significantly inhibited by 50 μmol/L indomethacin after 6 or 24 h incubation of femoral or tibial cartilage explants in organ culture. This is in accord with previous observations in human or porcine articular cartilage under the same culture conditions. Studies were performed in vivo to establish the effects of the NSAIDs on joint integrity. This involved determining cartilage proteoglycan synthesis ex vivo, leukocyte, fluid and protein accumulation, as well as pain relief. Thus, meloxicam (0.2 mg/kg i.v. x 3 doses) or indomethacin (0.5 mg/kg i.v. x 3 doses) was given for 26 h and the effects were compared with a control (1.0 ml saline i.v. x 3 doses) in dogs in which acute inflammation had been induced by intra-articular (i.a.) injection of calcium pyrophosphate dihydrate (CPPD) crystals into the right stifle joint, an equivalent volume of saline being injected into the left stifle joint as a control. No effects were observed of the treatment with the NSAIDs on ex vivo sulphated proteoglycan synthesis. The lack of the expected inhibitory effects of indomethacin may be related to the relatively low plasma concentrations of this drug obtained during the 26 h period of treatment. The pain response, which was elicited up to 6 h following i.a. injection of CPPD crystals, was totally prevented by the treatment with meloxicam and to a lesser extent with indomethacin. There were no effects from the drug treatment on synovial inflammatory reactions (fluid and cell accumulation), although the protein concentration of the exudate was reduced by meloxicam. This indicates that, at the doses given, it was possible to discriminate the analgesic action from the anti-inflammatory action of the two NSAIDs, this being achieved at relatively low plasma concentrations of these drugs. In conclusion, while relatively high therapeutic concentrations of indomethacin inhibit cartilage proteoglycan synthesis, this is not an effect seen even at high concentrations of meloxicam. Furthermore, the lack of effects on proteoglycan synthesis was evident when these two drugs were given in vivo to dogs. However, the signs of pain, but not the inflammation in the joint, were relieved by low plasma concentrations of the drugs. Meloxicam may thus be safely employed for acute analgesia without the potential risks of joint cartilage damage that occurs with indomethacin given at anti-inflammatory doses for long periods of time.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rainsford</api:last-name><api:initials>KD</api:initials><api:first-names>KD</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Sheffield Hallam University</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="CA"><api:line type="organisation">McMaster University</api:line><api:line type="city">Hamilton</api:line><api:line type="country">Canada</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005167251</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7004271201</api:identifier></api:identifiers></api:person><api:person><api:last-name>Chindemi</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">McMaster University</api:line><api:line type="city">Hamilton</api:line><api:line type="country">Canada</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57215944135</api:identifier></api:identifiers></api:person><api:person><api:last-name>Delaney</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">McMaster University</api:line><api:line type="city">Hamilton</api:line><api:line type="country">Canada</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005548918</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1023/A:1006254402163</api:text><api:links><api:link type="doi" href="http://doi.org/10.1023/A:1006254402163"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1023/A:1006254402163"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10359154</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0165-7380</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Veterinary Research Communications</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>101</api:begin-page><api:end-page>113</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of the NSAIDs Meloxicam and Indomethacin on Cartilage Proteoglycan Synthesis and Joint Responses to Calcium Pyrophosphate Crystals in Dogs</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>23</api:text></api:field></api:native></api:record><api:record format="native" id="292" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10359154" last-modified-when="2023-04-25T23:18:39.58+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>NSAIDs are a major cause for concern for their propensity to cause joint deterioration in canine, as in human, patients receiving these drugs for treatment of pain in osteoarthritis and other acute and chronic painful conditions. To determine the potential effects of the new NSAID meloxicam on cartilage integrity, the effects of this drug on proteoglycan biosynthesis in vitro and ex vivo were compared with those of indomethacin, a known inhibitor of sulphated proteoglycans that accelerates joint injury in human osteoarthritis. In vitro cartilage proteoglycan synthesis from a radiosulphate precursor was unaffected by 0.5-10.0 micromol/L meloxicam but was significantly inhibited by 50 micromol/L indomethacin after 6 or 24 h incubation of femoral or tibial cartilage explants in organ culture. This is in accord with previous observations in human or porcine articular cartilage under the same culture conditions. Studies were performed in vivo to establish the effects of the NSAIDs on joint integrity. This involved determining cartilage proteoglycan synthesis ex vivo, leukocyte, fluid and protein accumulation, as well as pain relief. Thus, meloxicam (0.2 mg/kg i.v. x 3 doses) or indomethacin (0.5 mg/kg i.v. x 3 doses) was given for 26 h and the effects were compared with a control (1.0 ml saline i.v. x 3 doses) in dogs in which acute inflammation had been induced by intra-articular (i.a.) injection of calcium pyrophosphate dihydrate (CPPD) crystals into the right stifle joint, an equivalent volume of saline being injected into the left stifle joint as a control. No effects were observed of the treatment with the NSAIDs on ex vivo sulphated proteoglycan synthesis. The lack of the expected inhibitory effects of indomethacin may be related to the relatively low plasma concentrations of this drug obtained during the 26 h period of treatment. The pain response, which was elicited up to 6 h following i.a. injection of CPPD crystals, was totally prevented by the treatment with meloxicam and to a lesser extent with indomethacin. There were no effects from the drug treatment on synovial inflammatory reactions (fluid and cell accumulation), although the protein concentration of the exudate was reduced by meloxicam. This indicates that, at the doses given, it was possible to discriminate the analgesic action from the anti-inflammatory action of the two NSAIDs, this being achieved at relatively low plasma concentrations of these drugs. In conclusion, while relatively high therapeutic concentrations of indomethacin inhibit cartilage proteoglycan synthesis, this is not an effect seen even at high concentrations of meloxicam. Furthermore, the lack of effects on proteoglycan synthesis was evident when these two drugs were given in vivo to dogs. However, the signs of pain, but not the inflammation in the joint, were relieved by low plasma concentrations of the drugs. Meloxicam may thus be safely employed for acute analgesia without the potential risks of joint cartilage damage that occurs with indomethacin given at antiinflammatory doses for long periods of time.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rainsford</api:last-name><api:initials>KD</api:initials><api:first-names>KD</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Biomedical Sciences, School of Science and Mathematics, Sheffield Hallam University, Sheffield, UK.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Chindemi</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Delaney</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10359154</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1023/a:1006254402163</api:text><api:links><api:link type="doi" href="http://doi.org/10.1023/a:1006254402163"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1023/a:1006254402163"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0165-7380</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Vet Res Commun</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Anti-Inflammatory Agents, Non-Steroidal</api:keyword><api:keyword scheme="mesh">Arthritis</api:keyword><api:keyword scheme="mesh">Calcium Pyrophosphate</api:keyword><api:keyword scheme="mesh">Cartilage</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Dog Diseases</api:keyword><api:keyword scheme="mesh">Dogs</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Indomethacin</api:keyword><api:keyword scheme="mesh">Joints</api:keyword><api:keyword scheme="mesh">Meloxicam</api:keyword><api:keyword scheme="mesh">Proteoglycans</api:keyword><api:keyword scheme="mesh">Synovitis</api:keyword><api:keyword scheme="mesh">Thiazines</api:keyword><api:keyword scheme="mesh">Thiazoles</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Switzerland</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>101</api:begin-page><api:end-page>113</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>3</api:day><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>23</api:text></api:field></api:native></api:record><api:record format="native" id="873040" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10359154" last-modified-when="2020-08-18T23:30:49.14+01:00"><api:citation-count>14</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>NSAIDs are a major cause for concern for their propensity to cause joint deterioration in canine, as in human, patients receiving these drugs for treatment of pain in osteoarthritis and other acute and chronic painful conditions. To determine the potential effects of the new NSAID meloxicam on cartilage integrity, the effects of this drug on proteoglycan biosynthesis in vitro and ex vivo were compared with those of indomethacin, a known inhibitor of sulphated proteoglycans that accelerates joint injury in human osteoarthritis. In vitro cartilage proteoglycan synthesis from a radiosulphate precursor was unaffected by 0.5-10.0 micromol/L meloxicam but was significantly inhibited by 50 micromol/L indomethacin after 6 or 24 h incubation of femoral or tibial cartilage explants in organ culture. This is in accord with previous observations in human or porcine articular cartilage under the same culture conditions. Studies were performed in vivo to establish the effects of the NSAIDs on joint integrity. This involved determining cartilage proteoglycan synthesis ex vivo, leukocyte, fluid and protein accumulation, as well as pain relief. Thus, meloxicam (0.2 mg/kg i.v. x 3 doses) or indomethacin (0.5 mg/kg i.v. x 3 doses) was given for 26 h and the effects were compared with a control (1.0 ml saline i.v. x 3 doses) in dogs in which acute inflammation had been induced by intra-articular (i.a.) injection of calcium pyrophosphate dihydrate (CPPD) crystals into the right stifle joint, an equivalent volume of saline being injected into the left stifle joint as a control. No effects were observed of the treatment with the NSAIDs on ex vivo sulphated proteoglycan synthesis. The lack of the expected inhibitory effects of indomethacin may be related to the relatively low plasma concentrations of this drug obtained during the 26 h period of treatment. The pain response, which was elicited up to 6 h following i.a. injection of CPPD crystals, was totally prevented by the treatment with meloxicam and to a lesser extent with indomethacin. There were no effects from the drug treatment on synovial inflammatory reactions (fluid and cell accumulation), although the protein concentration of the exudate was reduced by meloxicam. This indicates that, at the doses given, it was possible to discriminate the analgesic action from the anti-inflammatory action of the two NSAIDs, this being achieved at relatively low plasma concentrations of these drugs. In conclusion, while relatively high therapeutic concentrations of indomethacin inhibit cartilage proteoglycan synthesis, this is not an effect seen even at high concentrations of meloxicam. Furthermore, the lack of effects on proteoglycan synthesis was evident when these two drugs were given in vivo to dogs. However, the signs of pain, but not the inflammation in the joint, were relieved by low plasma concentrations of the drugs. Meloxicam may thus be safely employed for acute analgesia without the potential risks of joint cartilage damage that occurs with indomethacin given at antiinflammatory doses for long periods of time.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Biomedical Sciences, School of Science and Mathematics, Sheffield Hallam University, Sheffield, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rainsford</api:last-name><api:initials>KD</api:initials><api:first-names>KD</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0003-1319-5575</api:identifier></api:identifiers></api:person><api:person><api:last-name>Chindemi</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Delaney</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1023/a:1006254402163</api:text><api:links><api:link type="doi" href="http://doi.org/10.1023/a:1006254402163"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1023/a:1006254402163"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1573-7446</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10359154</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0165-7380</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Veterinary research communications</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cartilage</api:keyword><api:keyword scheme="mesh">Joints</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Dogs</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Arthritis</api:keyword><api:keyword scheme="mesh">Synovitis</api:keyword><api:keyword scheme="mesh">Dog Diseases</api:keyword><api:keyword scheme="mesh">Calcium Pyrophosphate</api:keyword><api:keyword scheme="mesh">Thiazines</api:keyword><api:keyword scheme="mesh">Thiazoles</api:keyword><api:keyword scheme="mesh">Indomethacin</api:keyword><api:keyword scheme="mesh">Proteoglycans</api:keyword><api:keyword scheme="mesh">Anti-Inflammatory Agents, Non-Steroidal</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Meloxicam</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>101</api:begin-page><api:end-page>113</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>8</api:day><api:month>6</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>23</api:text></api:field></api:native></api:record><api:record format="native" id="2472354" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1010047612" last-modified-when="2024-03-18T00:27:35.737+00:00"><api:citation-count>30</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rainsford</api:last-name><api:initials>KD</api:initials><api:first-names>KD</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Sheffield Hallam University</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="CA"><api:line type="organisation">McMaster University</api:line><api:line type="city">Hamilton</api:line><api:line type="state">Ontario</api:line><api:line type="country">Canada</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01040141112.62</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of York</api:line><api:line type="city">York</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.012630454524.58</api:identifier></api:identifiers></api:person><api:person><api:last-name>Chindemi</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">McMaster University</api:line><api:line type="city">Hamilton</api:line><api:line type="state">Ontario</api:line><api:line type="country">Canada</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01236717315.04</api:identifier></api:identifiers></api:person><api:person><api:last-name>Delaney</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">McMaster University</api:line><api:line type="city">Hamilton</api:line><api:line type="state">Ontario</api:line><api:line type="country">Canada</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0643734203.85</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1023/a:1006254402163</api:text><api:links><api:link type="doi" href="http://doi.org/10.1023/a:1006254402163"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1023/a:1006254402163"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10359154</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0165-7380</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Veterinary Research Communications</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3009 Veterinary Sciences</api:keyword><api:keyword scheme="for-2020">30 Agricultural, Veterinary and Food Sciences</api:keyword><api:keyword scheme="rcdc">Chronic Pain</api:keyword><api:keyword scheme="rcdc">Arthritis</api:keyword><api:keyword scheme="rcdc">Pain Research</api:keyword><api:keyword scheme="hrcs-rac">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac">5.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-hc">Musculoskeletal</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Anti-Inflammatory Agents, Non-Steroidal</api:keyword><api:keyword scheme="mesh">Arthritis</api:keyword><api:keyword scheme="mesh">Calcium Pyrophosphate</api:keyword><api:keyword scheme="mesh">Cartilage</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Dog Diseases</api:keyword><api:keyword scheme="mesh">Dogs</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Indomethacin</api:keyword><api:keyword scheme="mesh">Joints</api:keyword><api:keyword scheme="mesh">Meloxicam</api:keyword><api:keyword scheme="mesh">Proteoglycans</api:keyword><api:keyword scheme="mesh">Synovitis</api:keyword><api:keyword scheme="mesh">Thiazines</api:keyword><api:keyword scheme="mesh">Thiazoles</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>101</api:begin-page><api:end-page>113</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.79</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of the NSAIDs Meloxicam and Indomethacin on Cartilage Proteoglycan Synthesis and Joint Responses to Calcium Pyrophosphate Crystals in Dogs</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>23</api:text></api:field></api:native></api:record><api:record format="native" id="240106" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000080234200004" last-modified-when="2024-03-14T05:52:01.977+00:00"><api:citation-count>28</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rainsford</api:last-name><api:initials>KD</api:initials><api:first-names>KD</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Chindemi</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Delaney</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000080234200004&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1023/A:1006254402163</api:text><api:links><api:link type="doi" href="http://doi.org/10.1023/A:1006254402163"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1023/A:1006254402163"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1573-7446</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">195DQ</api:identifier><api:identifier scheme="pubmed">10359154</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0165-7380</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>VETERINARY RESEARCH COMMUNICATIONS</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>analgesia</api:keyword><api:keyword>arthritis</api:keyword><api:keyword>dogs</api:keyword><api:keyword>indomethacin</api:keyword><api:keyword>joint injury</api:keyword><api:keyword>meloxicam</api:keyword><api:keyword>NSAID</api:keyword><api:keyword>pain</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>101</api:begin-page><api:end-page>113</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>23</api:text></api:field></api:native></api:record><api:record format="native" id="22700" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000080234200004" last-modified-when="2014-07-25T11:02:07.393+01:00"><api:citation-count>24</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rainsford</api:last-name><api:initials>KD</api:initials><api:first-names>KD</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Chindemi</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Delaney</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0165-7380</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>VET RES COMMUN</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>analgesia</api:keyword><api:keyword>arthritis</api:keyword><api:keyword>dogs</api:keyword><api:keyword>indomethacin</api:keyword><api:keyword>joint injury</api:keyword><api:keyword>meloxicam</api:keyword><api:keyword>NSAID</api:keyword><api:keyword>pain</api:keyword><api:keyword>ANTI-INFLAMMATORY DRUGS</api:keyword><api:keyword>OSTEOARTHRITIS</api:keyword><api:keyword>PHARMACOKINETICS</api:keyword><api:keyword>MODEL</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>101</api:begin-page><api:end-page>113</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>23</api:text></api:field></api:native></api:record><api:record format="native" id="358985" source-id="1" source-name="manual" source-display-name="Manual" id-at-source="E0361987-19E4-4AE3-9208-9C455AC51E88" last-modified-when="2014-07-25T11:02:07.41+01:00"><api:verification-status>unverified</api:verification-status><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>NSAIDs are a major cause for concern for their propensity to cause joint deterioration in canine, as in human, patients receiving these drugs for treatment of pain in osteoarthritis and other acute and chronic painful conditions. To determine the potential effects of the new NSAID meloxicam on cartilage integrity, the effects of this drug on proteoglycan biosynthesis in vitro and ex vivo were compared with those of indomethacin, a known inhibitor of sulphated proteoglycans that accelerates joint injury in human osteoarthritis. In vitro cartilage proteoglycan synthesis from a radiosulphate precursor was unaffected by 0.5-10.0 micromol/L meloxicam but was significantly inhibited by 50 micromol/L indomethacin after 6 or 24 h incubation of femoral or tibial cartilage explants in organ culture. This is in accord with previous observations in human or porcine articular cartilage under the same culture conditions. Studies were performed in vivo to establish the effects of the NSAIDs on joint integrity. This involved determining cartilage proteoglycan synthesis ex vivo, leukocyte, fluid and protein accumulation, as well as pain relief. Thus, meloxicam (0.2 mg/kg i.v. x 3 doses) or indomethacin (0.5 mg/kg i.v. x 3 doses) was given for 26 h and the effects were compared with a control (1.0 ml saline i.v. x 3 doses) in dogs in which acute inflammation had been induced by intra-articular (i.a.) injection of calcium pyrophosphate dihydrate (CPPD) crystals into the right stifle joint, an equivalent volume of saline being injected into the left stifle joint as a control. No effects were observed of the treatment with the NSAIDs on ex vivo sulphated proteoglycan synthesis. The lack of the expected inhibitory effects of indomethacin may be related to the relatively low plasma concentrations of this drug obtained during the 26 h period of treatment. The pain response, which was elicited up to 6 h following i.a. injection of CPPD crystals, was totally prevented by the treatment with meloxicam and to a lesser extent with indomethacin. There were no effects from the drug treatment on synovial inflammatory reactions (fluid and cell accumulation), although the protein concentration of the exudate was reduced by meloxicam. This indicates that, at the doses given, it was possible to discriminate the analgesic action from the anti-inflammatory action of the two NSAIDs, this being achieved at relatively low plasma concentrations of these drugs. In conclusion, while relatively high therapeutic concentrations of indomethacin inhibit cartilage proteoglycan synthesis, this is not an effect seen even at high concentrations of meloxicam. Furthermore, the lack of effects on proteoglycan synthesis was evident when these two drugs were given in vivo to dogs. However, the signs of pain, but not the inflammation in the joint, were relieved by low plasma concentrations of the drugs. Meloxicam may thus be safely employed for acute analgesia without the potential risks of joint cartilage damage that occurs with indomethacin given at antiinflammatory doses for long periods of time.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rainsford</api:last-name><api:initials>KD</api:initials><api:first-names>KD</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1097" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1097"/></api:links><api:last-name>Skerry</api:last-name><api:initials>TM</api:initials><api:first-names>TM</api:first-names><api:separate-first-names><api:first-name>T</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Chindemi</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Delaney</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=10359154</api:text></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0165-7380</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Veterinary research communications</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Animals Anti-Inflammatory Agents, Non-Steroidal/*pharmacology Arthritis/chemically induced/metabolism/veterinary Calcium Pyrophosphate/*metabolism Cartilage/drug effects/*metabolism Crystallization Dog Diseases/chemically induced/metabolism Dogs/*metabolism Humans Indomethacin/*pharmacology Joints/*drug effects Proteoglycans/*biosynthesis Synovitis/chemically induced/metabolism/veterinary Thiazines/*pharmacology Thiazoles/*pharmacology</api:keyword></api:keywords></api:field><api:field name="notes" type="text" display-name="Other information"><api:text>Mar
Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs
Rainsford, K D Skerry, T M Chindemi, P Delaney, K Research Support, Non-U.S. Gov't Netherlands Veterinary research communications Vet Res Commun. 1999 Mar;23(2):101-13.
eng
</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>101</api:begin-page><api:end-page>113</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>17</api:day><api:month>1</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>JOUR</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>23</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Anti-Inflammatory Agents, Non-Steroidal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Arthritis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Calcium Pyrophosphate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cartilage</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Crystallization</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Dog Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Dogs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Indomethacin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Joints</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Meloxicam</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Synovitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Thiazines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Thiazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cartilage</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Joints</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Dogs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Arthritis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Synovitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Dog Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Calcium Pyrophosphate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Thiazines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Thiazoles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Indomethacin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Anti-Inflammatory Agents, Non-Steroidal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Crystallization</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Meloxicam</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3009 Veterinary Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">30 Agricultural, Veterinary and Food Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Chronic Pain</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Arthritis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Pain Research</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Musculoskeletal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Anti-Inflammatory Agents, Non-Steroidal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Arthritis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Calcium Pyrophosphate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cartilage</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Crystallization</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Dog Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Dogs</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Indomethacin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Joints</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Meloxicam</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Synovitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Thiazines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Thiazoles</api:keyword><api:keyword origin="record-data" source="wos-lite">analgesia</api:keyword><api:keyword origin="record-data" source="wos-lite">arthritis</api:keyword><api:keyword origin="record-data" source="wos-lite">dogs</api:keyword><api:keyword origin="record-data" source="wos-lite">indomethacin</api:keyword><api:keyword origin="record-data" source="wos-lite">joint injury</api:keyword><api:keyword origin="record-data" source="wos-lite">meloxicam</api:keyword><api:keyword origin="record-data" source="wos-lite">NSAID</api:keyword><api:keyword origin="record-data" source="wos-lite">pain</api:keyword><api:keyword origin="record-data" source="wos">analgesia</api:keyword><api:keyword origin="record-data" source="wos">arthritis</api:keyword><api:keyword origin="record-data" source="wos">dogs</api:keyword><api:keyword origin="record-data" source="wos">indomethacin</api:keyword><api:keyword origin="record-data" source="wos">joint injury</api:keyword><api:keyword origin="record-data" source="wos">meloxicam</api:keyword><api:keyword origin="record-data" source="wos">NSAID</api:keyword><api:keyword origin="record-data" source="wos">pain</api:keyword><api:keyword origin="record-data" source="wos">ANTI-INFLAMMATORY DRUGS</api:keyword><api:keyword origin="record-data" source="wos">OSTEOARTHRITIS</api:keyword><api:keyword origin="record-data" source="wos">PHARMACOKINETICS</api:keyword><api:keyword origin="record-data" source="wos">MODEL</api:keyword><api:keyword origin="record-data" source="manual">Animals Anti-Inflammatory Agents, Non-Steroidal/*pharmacology Arthritis/chemically induced/metabolism/veterinary Calcium Pyrophosphate/*metabolism Cartilage/drug effects/*metabolism Crystallization Dog Diseases/chemically induced/metabolism Dogs/*metabolism Humans Indomethacin/*pharmacology Joints/*drug effects Proteoglycans/*biosynthesis Synovitis/chemically induced/metabolism/veterinary Thiazines/*pharmacology Thiazoles/*pharmacology</api:keyword><api:keyword scheme="for" origin="issn-inferred">0707 Veterinary Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Veterinary Sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3009 Veterinary sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0165-7380" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/967873" title="Veterinary Research Communications"><api:records><api:record source-name="summary"><api:title>Veterinary Research Communications</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/292/relationships"/></api:object></api:result></api:response>